Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent suffering products and is also current at micromolar concentrations within the brain following systemic injection. Scientists believe that blocking this scavenger receptor implies that it can no longer protect against naturally manufactured opioids from interacting with other opioid receptors https://danielc470ejk0.ourabilitywiki.com/user